FibroGen, Inc. (FGEN)

FibroGen Revenue

In the year 2023, FibroGen had annual revenue of $147.75M with 4.99% growth. Revenue in the quarter ending December 31, 2023 was $27.14M, a -21.03% decrease year-over-year.

• Revenue (ttm): $147.75M
• Revenue Growth: +4.99%
• P/S Ratio: 0.76
• Revenue / Employee: $304,016
• Employees: 486
• Market Cap: 112.41M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	147.75M	7.02M	4.99%
Dec 31, 2022	140.73M	-94.58M	-40.19%
Dec 31, 2021	235.31M	58.99M	33.46%
Dec 31, 2020	176.32M	-80.26M	-31.28%
Dec 31, 2019	256.58M	43.62M	20.48%
Dec 31, 2018	212.96M	81.96M	62.57%
Dec 31, 2017	131.00M	-52.19M	-28.49%
Dec 31, 2016	183.19M	2.36M	1.31%
Dec 31, 2015	180.83M	43.23M	31.41%
Dec 31, 2014	137.60M	35.43M	34.68%
Dec 31, 2013	102.17M	36.24M	54.96%
Dec 31, 2012	65.93M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.